Treatment with AXS-05, a combination of dextromethorphan and bupropion, demonstrated rapid, sustained, and clinically meaningful improvement in agitation related to Alzheimer’s disease (AD) and was generally […]

There is no increased relapse risk in patients with multiple sclerosis (MS) and comorbid cancer who are receiving immune checkpoint inhibitor (ICI) therapy, results of a […]

Lidocaine injections into the greater occipital nerve relieve severe, refractory migraine attacks in children, results of a randomized controlled trial show.  Investigators found children receiving bilateral […]

DENVER, Colorado — A test to detect pathogens related to meningitis, encephalitis, and other neurologic infections is more sensitive than are conventional diagnostics and could vastly […]

DENVER, Colorado — Vaporized cannabis containing tetrahydrocannabinol (THC) and cannabidiol (CBD) may provide rapid and sustained relief of acute migraine pain with no serious side effects, […]

Headaches, including tension-type, migraine, and posttraumatic headache, are robustly associated with both attempted and completed suicide, results of a large study suggest.  The risk for suicide […]

Intravenous (IV) ketamine is an effective and safe treatment option for children with severe refractory headache, new research suggests.  In a retrospective chart review, IV ketamine […]

An interim analysis of an ongoing extension study supports the long-term safety and efficacy of the oral calcitonin gene-related peptide (CGRP) receptor antagonist atogepant (Qulipta) to […]

Seizure burden, defined by an artificial intelligence (AI) algorithm applied to point-of-care electroencephalography (POC EEG) recordings, can help predict functional outcomes. After relevant cofactors were controlled […]